NEW YORK (GenomeWeb News) - EraGen Biosciences said today that it has received Health Canada approval to market five quantitative PCR-based in vitro diagnostics in the Canadian market.
 
Health Canada approved the company’s tests for Bordetella pertussis and B. parapertussis; Enterovirus; influenza types A and B; herpes simplex virus 1 and 2; and cytomegalovirus.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.